Reports the approval of the Food and Drug Administration on celecoxib administration for familial adenomatous polyposis in the U.S. Expression of COX-2 in wounded tissue; Assessment on the efficacy of COX-2 inhibitors for several types of cancer; Pharmacological properties of celecoxib.